Insider Transactions in Q1 2025 at Enhabit, Inc. (EHAB)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 10
2025
|
Mark W Ohlendorf Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,404
+10.92%
|
$16,828
$7.8 P/Share
|
|
Jan 10
2025
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,404
+4.23%
|
$16,828
$7.8 P/Share
|
|
Jan 10
2025
|
Stuart M Mcguigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,404
+4.66%
|
$16,828
$7.8 P/Share
|
|
Jan 10
2025
|
Barry P. Schochet Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,045
+6.63%
|
$21,315
$7.8 P/Share
|
|
Jan 10
2025
|
Gregory S Rush Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,205
+5.96%
|
$22,435
$7.8 P/Share
|
|
Jan 10
2025
|
Erin Hoeflinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,045
+5.6%
|
$21,315
$7.8 P/Share
|
|
Jan 10
2025
|
Jeffrey Bolton Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,808
+4.46%
|
$33,656
$7.8 P/Share
|
|
Jan 01
2025
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,458
-2.5%
|
$24,206
$7.81 P/Share
|
|
Jan 01
2025
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,834
-1.8%
|
$117,838
$7.81 P/Share
|
|
Jan 01
2025
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,687
-1.5%
|
$11,809
$7.81 P/Share
|
|
Jan 01
2025
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,800
-2.13%
|
$12,600
$7.81 P/Share
|